Genotype MTBDRsl version 2 and phenotypic drug resistance detection of Mycobacterium tuberculosis for fluoroquinolones and aminoglycosides

MLA

Ramalingam Radhakrishnan, et al. “Genotype MTBDRsl Version 2 and Phenotypic Drug Resistance Detection of Mycobacterium Tuberculosis for Fluoroquinolones and Aminoglycosides.” International Journal of Mycobacteriology, vol. 12, no. 3, Jan. 2023, pp. 299–304. EBSCOhost, https://doi.org/10.4103/ijmy.ijmy_120_23.

APA

Ramalingam Radhakrishnan, S Prabuseenivasan, S Hannah, V Vaishanavee, V Senthildevi, T Kannadhasan, R Suchithra, Priya Rajendran, Ponnuraja Chinnaiyan, Lavanya Jayabal, Asha Frederick, & Sivakumar Shanmugam. (2023). Genotype MTBDRsl version 2 and phenotypic drug resistance detection of Mycobacterium tuberculosis for fluoroquinolones and aminoglycosides. International Journal of Mycobacteriology, 12(3), 299–304. https://doi.org/10.4103/ijmy.ijmy_120_23

Chicago

Ramalingam Radhakrishnan, S Prabuseenivasan, S Hannah, V Vaishanavee, V Senthildevi, T Kannadhasan, R Suchithra, et al. 2023. “Genotype MTBDRsl Version 2 and Phenotypic Drug Resistance Detection of Mycobacterium Tuberculosis for Fluoroquinolones and Aminoglycosides.” International Journal of Mycobacteriology 12 (3): 299–304. doi:10.4103/ijmy.ijmy_120_23.